These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10546573)

  • 1. Colon cancer linked to diabetes.
    Health News; 1999 May; 5(6):6. PubMed ID: 10546573
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 2 diabetes mellitus and colorectal cancer risk: is homocysteine the missing link?
    Phelip JM; Roblin X
    Am J Gastroenterol; 2007 Feb; 102(2):466-7. PubMed ID: 17311671
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 2 diabetes mellitus, smoking, and colorectal cancer.
    Gibbs P; Steel S; McLaughlin S; Jones I; Faragher I; Skinner I; Croxford M; Johns J; Chapman M; Lipton L
    Am J Gastroenterol; 2007 Apr; 102(4):909-10. PubMed ID: 17397419
    [No Abstract]   [Full Text] [Related]  

  • 4. Colorectal cancer associated with BMI, physical activity, diabetes, and blood glucose.
    Lund Nilsen TI; Vatten LJ
    IARC Sci Publ; 2002; 156():257-8. PubMed ID: 12484182
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colorectal carcinoma and diabetes mellitus].
    Procházka V; Chlup R
    Vnitr Lek; 2008 Oct; 54(10):979-84. PubMed ID: 19009765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, colorectal cancer and cyclooxygenase 2 inhibition.
    Smith CJ; McKay GA; Fisher M
    Int J Clin Pract; 2008 May; 62(5):810-5. PubMed ID: 18373616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
    Larsson SC; Orsini N; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(22):1679-87. PubMed ID: 16288121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
    Schiel R; Müller UA; Braun A; Stein G; Kath R
    Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinemia in patients with colorectal cancer.
    Suehiro T; Matsumata T; Shikada Y; Sugimachi K
    Hepatogastroenterology; 2005; 52(61):76-8. PubMed ID: 15782998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes, insulin, and risk of cancer.
    Schiel R; Beltschikow W; Steiner T; Stein G
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and outcomes of colorectal cancer.
    Jullumstrø E; Kollind M; Lydersen S; Edna TH
    Acta Oncol; 2009; 48(3):361-7. PubMed ID: 19101848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.
    Limburg PJ; Vierkant RA; Fredericksen ZS; Leibson CL; Rizza RA; Gupta AK; Ahlquist DA; Melton LJ; Sellers TA; Cerhan JR
    Am J Gastroenterol; 2006 Aug; 101(8):1872-9. PubMed ID: 16790032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea.
    Chung YW; Han DS; Park KH; Eun CS; Yoo KS; Park CK
    Dis Colon Rectum; 2008 May; 51(5):593-7. PubMed ID: 18219529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal carcinoma screening in patients with type 2 diabetes mellitus].
    Nagel JM; Göke B
    Z Gastroenterol; 2006 Nov; 44(11):1153-65. PubMed ID: 17115358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.
    Tavani A; Bravi F; Bosetti C; Franceschi S; Levi F; Talamini R; La Vecchia C
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2277. PubMed ID: 16172246
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis.
    Nilsen TI; Vatten LJ
    Br J Cancer; 2001 Feb; 84(3):417-22. PubMed ID: 11161410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer mortality and factors related to the insulin resistance syndrome.
    Colangelo LA; Gapstur SM; Gann PH; Dyer AR; Liu K
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):385-91. PubMed ID: 11927499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China.
    Ren X; Zhang X; Zhang X; Gu W; Chen K; Le Y; Lai M; Zhu Y
    Public Health; 2009 Aug; 123(8):540-4. PubMed ID: 19664792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.